Encompass Health Corporation $EHC Shares Sold by Select Asset Management & Trust

Select Asset Management & Trust lowered its stake in shares of Encompass Health Corporation (NYSE:EHC) by 40.4% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 7,387 shares of the company’s stock after selling 5,000 shares during the quarter. Select Asset Management & Trust’s holdings in Encompass Health were worth $784,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. BNP Paribas Financial Markets increased its position in Encompass Health by 2.1% during the 4th quarter. BNP Paribas Financial Markets now owns 66,161 shares of the company’s stock worth $7,022,000 after purchasing an additional 1,358 shares in the last quarter. Norges Bank acquired a new stake in Encompass Health during the 4th quarter worth approximately $133,221,000. Eurizon Capital SGR S.p.A. acquired a new stake in Encompass Health during the 4th quarter worth approximately $143,000. Savant Capital LLC increased its position in Encompass Health by 44.8% during the 4th quarter. Savant Capital LLC now owns 5,162 shares of the company’s stock worth $548,000 after purchasing an additional 1,597 shares in the last quarter. Finally, Intech Investment Management LLC increased its position in Encompass Health by 505.6% during the 4th quarter. Intech Investment Management LLC now owns 132,225 shares of the company’s stock worth $14,034,000 after purchasing an additional 110,393 shares in the last quarter. Institutional investors and hedge funds own 97.25% of the company’s stock.

Insider Activity at Encompass Health

In other news, EVP Patrick William Tuer sold 682 shares of the stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the completion of the transaction, the executive vice president directly owned 24,755 shares in the company, valued at approximately $2,588,382.80. This represents a 2.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Treasurer Edmund Fay sold 11,937 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the transaction, the treasurer owned 89,325 shares of the company’s stock, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Corporate insiders own 1.80% of the company’s stock.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on EHC shares. Barclays dropped their target price on shares of Encompass Health from $153.00 to $140.00 and set an “overweight” rating for the company in a research report on Tuesday, May 5th. TD Cowen started coverage on shares of Encompass Health in a research report on Thursday. They set a “buy” rating and a $125.00 target price for the company. Leerink Partners set a $152.00 target price on shares of Encompass Health in a research report on Friday, May 22nd. Finally, Wall Street Zen raised shares of Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 2nd. Two equities research analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat.com, Encompass Health currently has an average rating of “Buy” and an average price target of $142.75.

Encompass Health Stock Down 3.1%

Shares of NYSE:EHC opened at $102.60 on Tuesday. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a 52-week low of $92.77 and a 52-week high of $127.99. The company has a 50 day moving average of $103.40 and a two-hundred day moving average of $105.28. The company has a market capitalization of $10.18 billion, a price-to-earnings ratio of 17.13, a price-to-earnings-growth ratio of 2.31 and a beta of 0.72.

Encompass Health (NYSE:EHC) last released its earnings results on Thursday, April 30th. The company reported $1.60 EPS for the quarter, beating the consensus estimate of $1.51 by $0.09. The company had revenue of $1.59 billion during the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.37 EPS. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. As a group, analysts forecast that Encompass Health Corporation will post 5.96 earnings per share for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, July 1st. Encompass Health’s dividend payout ratio is 12.69%.

Encompass Health Company Profile

Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.

Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.